C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8 + T cells within the tumor microenvironment
International Journal of Cancer · 2026
DOI: 10.1002/ijc.70252 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2026. Verfasst von Akito Tsuruta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Receptors, CXCR4, CD8-Positive T-Lymphocytes, Tumor Microenvironment, Circadian Rhythm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Immune checkpoint inhibitors (ICIs) are widely used to treat various types of cancer; however, their effectiveness varies, with some patients exhibiting resistance. Recent studies have shown that the efficacy of ICIs depends on the localization of immune cells, particularly T cells, within the tumor microenvironment (TME). Although the circadian clock is known to regulate immune cell migration into tumors, its role in orchestrating spatially precise intratumoral localization remains unclear. Here, we found that the distribution of CD8 + T cells within the TME varied according to the time of day, accompanied by diurnal expression of C‐X‐C chemokine receptor type 4 (CXCR4). The amplitude of the Cxcr4 expression rhythm was more pronounced in tumor‐infiltrated T cells than in those from the spleen and was associated with time‐dependent changes in their migration toward CXCL12‐expressing cancer‐associated fibroblasts (CAFs). Reanalysis of single‐cell RNA‐seq data from T cells of lung cancer patients also revealed that upregulation of CXCR4 expression in tumor‐infiltrated CD8 + T cells was linked to TGF‐β‐SMAD signaling. The TGF‐β‐SMAD signaling‐mediated transactivation of Cxcr4 was time‐dependently repressed by SMAD7, resulting in diurnal CXCR4 expression. Consequently, administration of a CXCR4 inhibitor during the circadian phase of elevated CXCR4 expression in tumor‐infiltrated CD8 + T cells promotes their dispersion throughout tumor tissues, thereby enhancing the efficacy of ICIs. Our findings highlight an unrecognized mechanism underlying diurnal changes in the aggregation and dispersion of CD8 + T cells within tumors, offering a novel approach to enhance the anti‐tumor immune effects of ICIs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
- Department of Clinical Pharmacokinetics, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.
ORCID-Profile: Akito Tsuruta, Tomoaki Yamauchi, Yuya Yoshida, Naoya Matsunaga, Satoru Koyanagi
Förderung
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
Zitieren
APA
Tsuruta, A., Fujimoto, M., Hiraoka, Y., Taniguchi, A., Shiiba, Y., Inoki, T., Yamauchi, T., Yoshida, Y., Matsunaga, N., Ohdo, S., & Koyanagi, S. (2026). C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8 + T cells within the tumor microenvironment. International Journal of Cancer. https://doi.org/10.1002/ijc.70252
Vancouver
Tsuruta A, Fujimoto M, Hiraoka Y, Taniguchi A, Shiiba Y, Inoki T, et al. C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8 + T cells within the tumor microenvironment. International Journal of Cancer. 2026. doi:10.1002/ijc.70252
BibTeX
@article{Tsuruta2026,
author = {Tsuruta, Akito and Fujimoto, Marina and Hiraoka, Yasuha and Taniguchi, Aoi and Shiiba, Yuki and Inoki, Takuto and Yamauchi, Tomoaki and Yoshida, Yuya and Matsunaga, Naoya and Ohdo, Shigehiro and Koyanagi, Satoru},
title = {C‐X‐C chemokine receptor CXCR4 mediates diurnal changes in the aggregation and dispersion of CD8 + T cells within the tumor microenvironment},
journal = {International Journal of Cancer},
year = {2026},
doi = {10.1002/ijc.70252}
}
EUVIMED